tirzepatide injection vial Eli Lilly Wins with Single-Dose Vials for Obesity Drug Zepbound®

While the discovery of therapeutic strategies targeting TICs holds promise, our understanding of TIC biology remains limited due to the challenges in identifying and isolating them

DSIPs regulatory influence on hormonal balance and stress pathways positions it as a promising option in peptide therapy to address sleep disturbances and associated conditions, improving quality of life and overall well-being

Li L, He D, Guo Q, Zhang Z, Ru D, Wang L, et al

The reason for this can be attributed to several factors: Increased Demand: Medications containing semaglutide and tirzepatide are currently listed on the FDA shortage list